Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin and Rifaximin in Decompensated Cirrhosis
NCT03150459Phase 2Completed
- Start
- Jul 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of simvastatin, rifaximin in decompensated cirrhosis. Started Jul 2017; status: completed.
02
Drugs
simvastatinrifaximin
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT03150459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150459.